Table 2. Distribution of Newly Detected Cancer Sites in ICS Screening Population (2011-12).
| Oral (C00-06)* |
Breast (C50)* |
Gynecological (C53-54)* |
Head and Neck (C09-C14, C32)* |
Others (C23, C67, C42)* |
|
|---|---|---|---|---|---|
| Total cases | 18 | 13 | 3 | 7 | 4 |
| Age | 54 (11.2) (35-74 yrs) |
57.9 (10.2) (43-72 yrs) |
68.7 (14.4) (58-85 yrs) |
60.4 (10.4) (45-75 yrs) |
58.5 (9.1) (46-68 yrs) |
| Sex | |||||
| Men | 88.9 | 0 | 0 | 71.4 | 50 |
| Women | 11.1 | 100 | 100 | 28.6 | 50 |
C00– lip C01-Base of tongue C02- Other parts of tongue C03-Gum C04-Floor of mouth C05-Palate C06- Other parts of mouth; C53- Cervix Uteri; C54- Corpus Uteri; C09-Tonsil C10-Oropharynx C11-Nasopharynx C12-Pyriform sinus C13-Hypopharynx C14Other ill-defined sites of lip, oral cavity and pharynx; C32- Larynx; C23- Gall bladder; C67- Urinary bladder; C42- Hematopoietic system